Bavarian Nordic CEO sees massive sales potential for Covid-19 vaccine after securing state aid

If the company manages to produce a Covid-19 vaccine, the sales potential will be huge, says CEO Paul Chaplin, who is happy about the recent aid agreement reached with the Danish government.
Bavarian Nordic CEO Paul Chaplin | Photo: PR/ Bavarian Nordic
Bavarian Nordic CEO Paul Chaplin | Photo: PR/ Bavarian Nordic
BY SIGNE FERSLEV PEDERSEN & LEONORA BECK, TRANSLATED BY CATHERINE BRETT

Bavarian Nordic CEO Paul Chaplin predicts huge growth potential for its Covid-19 vaccine, as a EUR 108m financial support agreement with the Danish government fell into place on Monday.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading